Product Overview: Clomixin (Clomid) –
Clomixin (Clomid) is a selective estrogen receptor modulator manufactured by Euro-Pharmacies for in-vitro research applications. Each tablet contains 50mg of clomiphene citrate, the active pharmaceutical ingredient that researchers examine for its dual agonist-antagonist properties at estrogen receptors. The compound demonstrates tissue-selective activity, functioning as an estrogen receptor antagonist in hypothalamic tissue while exhibiting agonist properties in other tissues. This research chemical is supplied in tablet form for convenient laboratory dosing and analytical studies. Researchers at Stroid UK Shop investigate clomiphene citrate alongside other compounds from our comprehensive clomiphene citrate collection to understand hormonal modulation mechanisms.
Research Applications
Laboratory studies examine clomiphene citrate’s mechanism of competitive inhibition at hypothalamic estrogen receptors, which results in increased gonadotropin-releasing hormone secretion in experimental models. Researchers analyse the compound’s ability to stimulate luteinizing hormone and follicle-stimulating hormone release through its anti-estrogenic action at the hypothalamus-pituitary axis. Cell culture investigations explore how clomiphene citrate modulates estrogen receptor signalling pathways and gene expression profiles. Scientists study the pharmacokinetics of clomiphene citrate metabolism, including its conversion to active metabolites and tissue distribution patterns. The compound serves as a reference standard in comparative studies with other SERMs and research chemicals from our SARMs catalogue and peptide research collection.
Specifications
| Active Ingredient | Clomiphene Citrate |
|---|---|
| Concentration | 50mg per tablet |
| Format | Oral tablets |
| Quantity | 50 tablets per bag |
| Manufacturer | Euro-Pharmacies |
| CAS Number | 50-41-9 |
| Molecular Formula | C₃₂H₃₆ClNO₈ |
| Storage | Room temperature, dry conditions |
Research Compliance
This product is manufactured by Euro-Pharmacies exclusively for in-vitro research purposes and laboratory analysis. Clomixin tablets are not intended for human consumption, therapeutic use, or any application outside controlled laboratory environments. Researchers must ensure proper handling protocols and regulatory compliance when studying this compound in their investigations.
